Protein Modifications as Potential Biomarkers in Breast Cancer
Journal Article
·
· Biomarker Insights, 2009(4):191-200
OSTI ID:972544
A variety of post-translational protein modifications (PTMs) are known to be altered as a result of cancer development. Thus, these PTMs are potentially useful biomarkers for breast cancer. Mass spectrometry, antibody microarrays and immunohistochemistry techniques have shown promise for identifying changes in PTMs. In this review, we summarize the current literature on PTMs identified in the plasma and tumor tissue of breast-cancer patients or in breast cell lines. We also discuss some of the analytical techniques currently being used to evaluate PTMs.
- Research Organization:
- Pacific Northwest National Laboratory (PNNL), Richland, WA (US)
- Sponsoring Organization:
- USDOE
- DOE Contract Number:
- AC05-76RL01830
- OSTI ID:
- 972544
- Report Number(s):
- PNNL-SA-69899; 400412000
- Journal Information:
- Biomarker Insights, 2009(4):191-200, Journal Name: Biomarker Insights, 2009(4):191-200 Vol. 4
- Country of Publication:
- United States
- Language:
- English
Similar Records
Protein Modifications as Potential Biomarkers in Breast Cancer
Plasma Biomarker Profiles Differ Depending on Breast Cancer Subtype but RANTES is Consistently Increased
Biomarker signatures of mitochondrial NDUFS3 in invasive breast carcinoma
Journal Article
·
Mon Nov 30 00:00:00 UTC 2009
· Biomarker Insights
·
OSTI ID:1629199
Plasma Biomarker Profiles Differ Depending on Breast Cancer Subtype but RANTES is Consistently Increased
Journal Article
·
Fri Jul 01 04:00:00 UTC 2011
· Cancer Epidemiology, Biomarkers and Prevention, 20(7):1543-1551
·
OSTI ID:1021271
Biomarker signatures of mitochondrial NDUFS3 in invasive breast carcinoma
Journal Article
·
Fri Sep 09 04:00:00 UTC 2011
· Biochemical and Biophysical Research Communications
·
OSTI ID:22207484